Medline Industries, LP has been the subject of 293 FDA enforcement/approval records tracked by Argus HQ, compared to 2 for Boehringer Ingelheim Pharmaceuticals, Inc..
Boehringer Ingelheim Pharmaceuticals, Inc.: 0 warning letters, 2 recalls, 0 approval records, 0 Form 483s.
Medline Industries, LP: 0 warning letters, 293 recalls, 0 approval records, 0 Form 483s.
Side by side
Boehringer Ingelheim Pharmaceuticals, Inc. — Warning letters0
Medline Industries, LP — Warning letters0
Boehringer Ingelheim Pharmaceuticals, Inc. — Recalls2
Medline Industries, LP — Recalls293
Boehringer Ingelheim Pharmaceuticals, Inc. — Approval records0
Medline Industries, LP — Approval records0
Boehringer Ingelheim Pharmaceuticals, Inc. — Form 483s0
Medline Industries, LP — Form 483s0
Timeline
Cite this comparison
Pre-formatted for a story, footnote, or reference list:
"Boehringer Ingelheim Pharmaceuticals, Inc. vs Medline Industries, LP: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/boehringer-ingelheim-pharmaceuticals-inc-vs-medline-industries-lp
Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗